Cart
sales@molnova.com
VHL-IN-15
CAS No. 1360616-29-0
VHL-IN-15( VHL-IN 15 | VHL IN-15 | VHL-IN-15 )
Catalog No. M11483 CAS No. 1360616-29-0
VHL-IN-15 is a potent (IC50=4.1 uM) von Hippel–Lindau protein (VHL) ligand that disrupts the VHL/HIF-1α interaction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVHL-IN-15
-
NoteResearch use only, not for human use.
-
Brief DescriptionVHL-IN-15 is a potent (IC50=4.1 uM) von Hippel–Lindau protein (VHL) ligand that disrupts the VHL/HIF-1α interaction.
-
DescriptionVHL-IN-15 is a potent (IC50=4.1 uM) von Hippel–Lindau protein (VHL) ligand that disrupts the VHL/HIF-1α interaction.
-
In Vitro——
-
In Vivo——
-
SynonymsVHL-IN 15 | VHL IN-15 | VHL-IN-15
-
PathwayProteasome/Ubiquitin
-
TargetE3 Ubiquitin Ligase
-
RecptorE3 Ubiquitin Ligase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1360616-29-0
-
Formula Weight410.43
-
Molecular FormulaC21H22N4O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C([C@H]1N(C(CC2=CC(C)=NO2)=O)C[C@H](O)C1)NCC3=CC=C(C4=CN=CO4)C=C3
-
Chemical Name(2S,4R)-4-hydroxy-1-(2-(3-methylisoxazol-5-yl)acetyl)-N-(4-(oxazol-5-yl)benzyl)pyrrolidine-2-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Buckley DL, et al. J Am Chem Soc. 2012 Mar 14;134(10):4465-8.
2. Van Molle I, et al. Chem Biol. 2012 Oct 26;19(10):1300-12.
molnova catalog
related products
-
HOIPIN-8
HOIPIN-8 (HOIP inhibitor-8) is a potent chemical inhibitor of linear ubiquitin chain assembly complex (LUBAC, IC50=11 nM).
-
NRX-252114
NRX-252114 (NRX 252114, NRX252114) is a potent, small molecule enhancer of β-catenin-β-TrCP interaction, potentiates pSer33/S37A β-catenin binding and ubiquitylation (EC50=6.5 nM).
-
cIAP1 E3 ligase inhi...
cIAP1 E3 ligase inhibitor D19-14 (cIAP1 inhibitor D19-14) is an improved analog of D19, demonstrates significantly increased ability to inhibit cIAP1 autoubiquitination and reduce protein levels of c-MYC in vitro.
